Pre-existing disease is associated with a significantly higher risk of death in severe respiratory syncytial virus infection

被引:156
|
作者
Thorburn, K. [1 ]
机构
[1] Royal Liverpool Childrens Hosp, Dept Paediat Intens Care, Liverpool L12 2AP, Merseyside, England
关键词
VIRAL-INFECTION; US CHILDREN; MORTALITY; BRONCHIOLITIS; INFANTS; INFLUENZA;
D O I
10.1136/adc.2008.139188
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background: 600 000 deaths worldwide are estimated to be directly or indirectly attributable to respiratory syncytial virus (RSV). Objectives: To determine: ( 1) the mortality rate; and ( 2) risk factors for death in children with severe RSV infection. Setting: 20-bed, regional, multidisciplinary, tertiary, paediatric intensive care unit (PICU) in a university-affiliated children's hospital. Methods: Cohort study of all children with severe RSV infection covering eight consecutive RSV seasons (1999-2007), using PICU admission as a marker of severity. Results: Of the 406 RSV-positive patients that were admitted to PICU: 98.5% required mechanical ventilation; 35 children died-median age 5.1 months (interquartile range (IQR) 2.4-13.6), length of PICU stay 16 days ( IQR 8-31) and 371 survived-median age 2.5 months ( IQR 1.2-9), length of PICU stay 5 days ( IQR 4-9). The overall PICU RSV mortality was 8.6% with a standardised mortality ratio of 0.76. During the study period 2009 RSV-positive patients were admitted to the children's hospital, giving a hospital RSV mortality rate of 1.7%. Of the deaths, 18 were directly RSV related ( RSV bronchiolitis-related mortality PICU 4.4% and hospital 0.9%) as the patients were still RSV positive when they died and 17 children died from non-pneumonitis causes after becoming RSV negative. All of the RSV deaths had pre-existing medical conditions -chromosomal abnormalities 29%, cardiac lesions 27%, neuromuscular 15%, chronic lung disease 12%, large airway abnormality 9%, and immunodeficiency 9%. Nineteen children (56%) had pre-existing disease in two or more organ systems ( relative risk (RR) 4.38). Predisposing risk factors for death were pre-existing disease ( RR 2.36), cardiac anomaly ( RR 2.98) and nosocomial/hospital-acquired RSV infection ( RR 2.89). There is an interaction effect between pre-existing disease, nosocomial/hospital-acquired RSV infection and mortality ( p < 0.001). Conclusions: Pre-existing disease/comorbidity, in particular multiple pre-existing diseases and cardiac anomaly, is associated with a significantly higher risk of death from severe RSV infection. Nosocomial/hospital-acquired RSV infection is an additional major risk factor for death in children with severe RSV infection.
引用
收藏
页码:99 / 103
页数:5
相关论文
共 50 条
  • [41] Extrapulmonary manifestations of severe respiratory syncytial virus infection – a systematic review
    Michael Eisenhut
    Critical Care, 10 (4):
  • [42] Risk Factors for Poor Outcome or Death in Young Children With Respiratory Syncytial Virus-Associated Acute Lower Respiratory Tract Infection: A Systematic Review and Meta-Analysis
    Shi, Ting
    Vennard, Sophie
    Mahdy, Sara
    Nair, Harish
    JOURNAL OF INFECTIOUS DISEASES, 2022, 226 (SUPPL 1): : S10 - S16
  • [43] Constitutive TRIM22 Expression in the Respiratory Tract Confers a Pre-Existing Defence Against Influenza A Virus Infection
    Charman, Matthew
    McFarlane, Steven
    Wojtus, Joanna K.
    Sloan, Elizabeth
    Dewar, Rebecca
    Leeming, Gail
    Al-Saadi, Mohammed
    Hunter, Laura
    Carroll, Miles W.
    Stewart, James P.
    Digard, Paul
    Hutchinson, Edward
    Boutell, Chris
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2021, 11
  • [44] Risk factors of respiratory syncytial virus infection among pediatric influenza-like illness and severe acute respiratory infections in Suzhou, China
    Huang, Yukai
    Hua, Jun
    Wang, Dan
    Chen, Liling
    Zhang, Jun
    Zhu, Hong
    Tian, Jianmei
    Zhang, Tao
    Zhao, Genming
    JOURNAL OF MEDICAL VIROLOGY, 2018, 90 (03) : 397 - 404
  • [45] Virus-Specific Antibody, Viral Load, and Disease Severity in Respiratory Syncytial Virus Infection
    Walsh, Edward E.
    Wang, Lu
    Falsey, Ann R.
    Qiu, Xing
    Corbett, Anthony
    Holden-Wiltse, Jeanne
    Mariani, Thomas J.
    Topham, David J.
    Caserta, Mary T.
    JOURNAL OF INFECTIOUS DISEASES, 2018, 218 (02): : 208 - 217
  • [46] A Narrative Review of Key Risk Factors for Severe Illness Following SARS-CoV-2, Influenza Virus, and Respiratory Syncytial Virus Infection
    Branche, Angela
    Ramesh, Mayur
    Francis, Beverly
    INFECTIOUS DISEASES AND THERAPY, 2025, 14 (SUPPL1) : 39 - 61
  • [47] Chemokines and their receptors in respiratory disease: a therapeutic target for respiratory syncytial virus infection
    Thomas, Lynette H.
    Friedland, Jon S.
    Sharland, Mike
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2007, 5 (03) : 415 - 425
  • [48] Burden of Respiratory Syncytial Virus Associated Severe Pneumonia in Hospitalized Children
    Gonapaladeniya, Madhusha
    Dissanayake, Thushari
    Liyanage, Guwani
    INTERNATIONAL JOURNAL OF PEDIATRICS, 2021, 2021
  • [49] Risk of respiratory syncytial virus in survivors with severe congenital diaphragmatic hernia
    Masumoto, Kouji
    Nagata, Kouji
    Uesugi, Toru
    Yamada, Tomomi
    Kinjo, Tadamune
    Hikino, Shunji
    Hara, Toshiro
    Taguchi, Tomoaki
    PEDIATRICS INTERNATIONAL, 2008, 50 (04) : 459 - 463
  • [50] Preventing severe respiratory syncytial virus disease: passive, active immunisation and new antivirals
    Murray, Joanna
    Saxena, Sonia
    Sharland, Mike
    ARCHIVES OF DISEASE IN CHILDHOOD, 2014, 99 (05) : 469 - 473